Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Argenx SE (ARGX US)
Watchlist
42
Analysis
Health Care
•
Netherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Ishares Global Consumer Disc
•
23 Jul 2022 00:28
Positive Signals; Growth Sectors Gaining Momentum; Buy Ideas Within Global Growth Sectors
Starting to see positive signals that suggest downside is limited from here. Still, we need to see reversals of YTD downtrends on $ACWI $ACWX $EFA...
Vermilion Research
Follow
444 Views
Share
bearish
•
Hang Seng Index
•
02 Jul 2022 00:24
Hang Seng, MSCI China Near Major Base Breakouts; Bottoms-Up Stock Rec's in Hong Kong, China, & Japan
Hong Kong's Hang Seng and China's $MCHI and $KWEB are near major base breakouts. We are watching is 22,700 on Hang Seng and $56.60 on MCHI; we are...
Vermilion Research
Follow
615 Views
Share
bearish
•
iShares MSCI ACWI ETF
•
25 Jun 2022 01:03
Inflation Peaking?; ACWI, ACWI Ex-US Near Support; Many Bottoms-Up Stock Recommendations
We're starting to see signs that inflation is peaking, as commodity prices have pulled back substantially or are breaking, and the Energy $XLE and...
Vermilion Research
Follow
527 Views
Share
bullish
•
Thematic (Sector/Industry)
•
27 Dec 2021 09:13
China Healthcare Weekly (Dec.24)- Capital Arbitrage, Drug Commercial Results, Healthcare Big Picture
This insight analyzed the concerns on capital arbitrage in domestic innovative drugs, the unsatisfactory innovative drug commercial results,...
Xinyao (Criss) Wang
Follow
353 Views
Share
bullish
•
Immunovant Inc
•
25 May 2021 21:46
MergerTalk: Why Skepticism Over A Potential Immunovant Buyout May Offer A Lucrative Opportunity
Why we think it is more likely than not that minority shareholders of Immunovant (IMVT US) will receive a buyout proposal with a hefty premium...
Robert Sassoon
Follow
340 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.36.0
x